share_log

歐康維視生物-B:二零二二年中期報告

Ocumension Therapeutics-B: 2022 Interim Report

Sep 20, 2022 04:47
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more